Advertisement
Advertisement

QNRX

QNRX logo

Quoin Pharmaceuticals, Ltd. - ADR

4.65
USD
Sponsored
+0.03
+0.65%
Jun 18, 15:52 UTC -4
Closed
exchange

After-Market

4.72

+0.07
+1.61%

QNRX Earnings Reports

Positive Surprise Ratio

QNRX beat 16 of 23 last estimates.

70%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$1.64
Implied change from Q1 26 (Revenue/ EPS)
--
/
-7.34%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-73.89%

Quoin Pharmaceuticals, Ltd. - ADR earnings per share and revenue

On May 07, 2026, QNRX reported earnings of -1.77 USD per share (EPS) for Q1 26, beating the estimate of -1.96 USD, resulting in a 9.93% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.93% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -1.64 USD, with revenue projected to reach -- USD, implying an decrease of -7.34% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q1 2026, Quoin Pharmaceuticals, Ltd. - ADR reported EPS of -$1.77, beating estimates by 9.93%, and revenue of $0.00, 0% as expectations.
The stock price moved down -0.93%, changed from $6.43 before the earnings release to $6.37 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 3 analysts, Quoin Pharmaceuticals, Ltd. - ADR is expected to report EPS of -$1.64 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement